{"version":"1.0","type":"link","title":"Efficacy and safety of a low-dose nivolumab regimen (240 mg) as neoadjuvant immunochemotherapy in Chinese patients with resectable non-small cell lung cancer: a prospective single-arm, exploratory study.","author_name":"Cheng Z 외","author_url":"https://prs-insight.online/author/Cheng%20Z","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/93660","thumbnail_width":1200,"thumbnail_height":630}